Track any pharma or biotech company's clinical trial portfolio in one place. DataLookout compares daily snapshots of ClinicalTrials.gov to detect phase transitions, new trial filings, status changes, and enrollment shifts across 86 disease areas — then delivers the changes to your dashboard and inbox.
See Pipeline Pulse Live →Everything you need to monitor competitor pipelines, from a single sponsor's portfolio to disease-level competitive landscapes.
Add any company and see their full trial portfolio — every active trial, organized by phase and disease, updated daily from ClinicalTrials.gov.
Know when a competitor's trial moves from Phase 2 to Phase 3, or when a Phase 1 trial quietly terminates. Changes are classified by severity.
Get notified when a sponsor registers a new trial on ClinicalTrials.gov. See the phase, disease area, and status before it shows up in any news feed.
See how a sponsor's pipeline distributes across diseases. Identify which therapeutic areas a company is expanding into or pulling back from.
86 disease areas with activity scoring, new trial counts, and new entrant detection. See which therapeutic areas are heating up across the industry.
Severity-classified changes delivered to your inbox every morning. Critical changes (status transitions, terminations) are flagged separately from routine updates.
Search for any company by name. Add them to your watchlist with one click. You'll see their full trial portfolio immediately.
DataLookout compares daily ClinicalTrials.gov snapshots using deterministic code. Every change to your watched sponsors' trials is detected and classified.
Status changes, phase transitions, new filings, enrollment shifts, and endpoint modifications appear on your dashboard and in your daily email digest.